UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C.
AMENDMENT TO FORM 10Q
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For Quarter Ended June 30, 1996 Commission File
Number: 0-28498
PARADIGM MEDICAL INDUSTRIES, INC.
---------------------------------
Exact Name of Registrant.
DELAWARE 87-0459536
- -------------------------------- ------------------
(State or other jurisdiction IRS Identification
of incorporation or organization) Number
1772 West 2300 South, Salt Lake City, Utah 84119
- ------------------------------------------ -----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number,
including Area Code (801) 977-8970
--------------
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Sections 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing
requirements for the past 90 days.
YES NO XX
----------- ----------
Indicate the number of shares outstanding for each of the issuer's
classes of common stock, net of treasury stock, as of the close
of the period covered by this report.
Class A Common Stock, $.001 par value 2,107,302
- ------------------------------------- ----------------
Title of Class Number of Shares
Outstanding as of
June 30, 1996
Series A Preferred, $.001 par value 122,764
- ------------------------------------- -----------------
Title of Class Number of Shares
Outstanding as of
June 30, 1996
Series B Preferred, $.001 par value 499,017
- ------------------------------------ -----------------
Title of Class Number of Shares
Outstanding as of
June 30, 1996
<PAGE>
PARADIGM MEDICAL INDUSTRIES, INC.
AMENDMENT TO FORM 10Q
QUARTER ENDED JUNE 30, 1996
TABLE OF CONTENTS
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements*
Item 2. Management's Discussion and Analysis of
Financial Condition and Results of
Operations*
PART II - OTHER INFORMATION
<TABLE>
<S> <C>
Page No.
--------
Items 1 through 5*
Item 6. . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Signature Page . . . . . . . . . . . . . . . . . . . . . . 4
*Incorporated by reference from Form 10-Q for period ending June
30, 1996, as filed August 20, 1996.
</TABLE>
<PAGE>
PART II - OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K.
The Company has not filed a report on Form 8-K during the quarter
for which this report is filed. The exhibits for the quarter are
as follows:
<TABLE>
<S> <C>
Exhibit
Number Document Description
- ------- --------------------
27. Financial Data Schedule.
</TABLE>
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act
of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
REGISTRANT
PARADIGM MEDICAL INDUSTRIES, INC.
---------------------------------
Registrant
DATED: October 9, 1996 By: Thomas F. Motter
President and Chief
Executive Officer
(Principal Executive
Officer)
DATED: October 9, 1996 By: John W. Hemmer
Treasurer and Chief
Financial Officer
(Principal Financial and
Accounting Officer)
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED BALANCE SHEET OF PARADIGM MEDICAL INDUSTRIES, INC. FOR THE NINE
MONTHS ENDED JUNE 30, 1996, AND THE RELATED STATEMENTS OF OPERATIONS AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> SEP-30-1996
<PERIOD-END> JUN-30-1996
<CASH> 204,862
<SECURITIES> 0
<RECEIVABLES> 117,375
<ALLOWANCES> 0
<INVENTORY> 363,775
<CURRENT-ASSETS> 690,513
<PP&E> 124,987
<DEPRECIATION> (22,377)
<TOTAL-ASSETS> 1,048,968
<CURRENT-LIABILITIES> 1,087,755
<BONDS> 0
0
622
<COMMON> 2,132
<OTHER-SE> (84,056)
<TOTAL-LIABILITY-AND-EQUITY> 1,048,968
<SALES> 291,022
<TOTAL-REVENUES> 291,022
<CGS> 154,077
<TOTAL-COSTS> 751,309
<OTHER-EXPENSES> 179,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (43,538)
<INCOME-PRETAX> (829,269)
<INCOME-TAX> 0
<INCOME-CONTINUING> (829,269)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (829,269)
<EPS-PRIMARY> (.35)
<EPS-DILUTED> (.35)
</TABLE>
